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Abstract
HIV infection increases the burden of disease of malaria in pregnancy, in part by impairing the development of immunity.
We measured total IgG and phagocytic antibodies against variant surface antigens of placental-type CS2 parasites in 187
secundigravidae (65% HIV infected). In women with placental malaria infection, phagocytic antibodies to CS2VSA were
decreased in the presence of HIV (p=0.011) and correlated positively with infant birth weight (coef=3.57, p=0.025),
whereas total IgG to CS2VSA did not. Phagocytic antibodies to CS2VSA are valuable tools to study acquired immunity to
malaria in the context of HIV co-infection. Secundigravidae may be an informative group for identification of correlates of
immunity.
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Introduction
Malaria in pregnancy is a major cause of mortality and
morbidity in malaria endemic regions, and the concomitant
presence of HIV worsens the adverse clinical outcomes with which
it is associated [1] When antibodies towards the variant surface
antigens of the placental-type parasite line CS2 (CS2VSA) were
analysed in a cohort of primigravidae from Malawi it became
apparent that HIV had a bigger impact on antibodies that
contribute to phagocytosis (hereafter mentioned as phagocytic
antibodies), particularly the acquisition phase of those antibodies,
than on the total IgG to CS2VSA [2] (also suggested by [3]). In
these primigravidae, unlike multigravidae (reviewed in [4])
antibody levels were not associated with infant birth weight or
maternal haemoglobin concentration. This lack of association was
attributed to the importance of the timing of the antibody
acquisition rather than to the levels of antibody achieved, and
subsequently measured, at the end of the pregnancy. It was
speculated, also, that in subsequent pregnancies the difference
between the effect of HIV on phagocytic antibodies and on total
IgG to CS2VSA would become more apparent, since HIV was
shown to affect the acquisition of phagocytic antibodies more than
the recall or maintenance of these responses. With this in mind, we
studied the function (opsonisation, measured as induction of
phagocytosis) and level (total IgG) of anti-CS2VSA antibodies in
secundigravidae (women in their second pregnancy) from the same
cohort in which we had previously studied the relationship
between placental malaria and HIV in primigravid cohort
members. We found that in secundigravidae, concentrations of
circulating phagocytic antibodies were modulated by the presence
of HIV, whereas the total levels of IgG to CS2VSA were not.
Among women with placental malaria at the end of their second
pregnancy, the measured levels of phagocytic antibodies to
CS2VSA at delivery correlated positively with infant birth weight.
Methods
Ethics statement
Ethical clearance for the study was provided by the College of
Medicine Research Ethics Committee, University of Malawi, the
Melbourne Health Human Research Ethics Committee, Mel-
bourne, Australia, and the Institutional Review Board of the
University of North Carolina, Chapel Hill, NC, USA.
Study samples
Serum samples came from a study group which has previously
been described [5,6]. In brief, women in late third trimester of
pregnancy consented to studies including HIV testing, and
samples of peripheral blood and placenta were collected. Only
secundigravid women for whom histology were reported to have
been performed (n=187) were included in the present study. All
samples were heat inactivated before use.
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22491Placental tissue, collected at delivery, was fixed in formalin and
Giemsa-stained sections were examined histologically as previously
described [7]. Placental malaria was considered to be present if
there was evidence of Plasmodium falciparum parasites or pigmented
monocytes or pigment in fibrin deposits in the placenta,
irrespective of peripheral blood parasitaemia.
We combined histology findings with results of microscopy of
Giemsa-stained placental and peripheral blood thick films to
allocate women to one of four groups: No Malaria (no evidence of
past or current malaria, either in blood films or placental
histology), Acute Infection (pRBC on placental histology, without
malaria pigment deposition), Chronic Infection (both pRBC and
malaria pigment deposits on histology) and Past Infection (placental
malaria pigment deposits, without pRBC on histology or on blood
films). We excluded from the grouping analysis women who
presented only with peripheral parasitaemia. All infections were
with P. falciparum.
Cell culture and Parasites
Thp-1 cells, obtained from the ATCC (catalog number: TIB-
202
TM), and the parasite lines CS2 and CS2-GFP were cultured
and maintained as previously described [2]. CS2 is similar to
placental-type isolates, binding to CSA and being recognised by
serum in a pregnancy-specific and gravidity-specific manner; CS2-
GFP shares these properties, and has been transfected to express
green fluorescent protein, using published techniques [8].
Antibody measurements: Assays of IgG to CS2VSA and the
phagocytosis assay
IgG to CS2VSAwas measured as described elsewhere [2] with
minor modifications. In summary, mid to late trophozoite-stage
CS2 parasitised red blood cells (pRBC) at 1–10% parasitaemia
were resuspended at 0.1% hematocrit in PBS with 1% newborn
calf serum (NCS) and incubated with test serum at 1/20 dilution
for 30 minutes in a 96-well plate at room temperature. Rabbit
anti-human IgG (Dako) 1/100 in PBS/ NCS and Alexafluor 488-
conjugated donkey anti-rabbit IgG (Invitrogen) at 1/500 dilution
in PBS/NCS containing 10 mg/ml EtBr were used as secondary
and tertiary antibodies, respectively. Cells were analysed on a
FACSCalibur flow cytometer with BD CellQuest
TM software
version 5.2.1 (BD Biosciences). The positive control was a pool of
serum with known high antibody recognition to CS2. Negative
controls were from unexposed Australian donors. MFI values for
RBC alone were subtracted from MFI of pRBC to obtain the
CS2VSA specific MFI. This was then converted into a percentage
of the positive control MFI, using the formula [9]:
Sample MFI-negative control MFI ðÞ |100=
Positive control MFI-negative control MFI ðÞ
The phagocytosis assay for the assessment of anti-CS2VSA
antibodies’ function was performed exactly as previously described
[2] with the only modification being the measurement of samples
in duplicate rather than in triplicate. In short, CS2-GFP pRBC
were opsonised with sample or control serum at 1/10 dilution in
96-well plates, washed thrice, added to uThp-1 cells at a 1:10 ratio
and left to phagocytose for 40 min in a humidified incubator with
5% CO2 at 37uC. After lysis of free pRBC with FACS Lysing
solution, cells were washed thrice, resuspended in 2% Parafor-
maldehyde in PBS and acquired on a FACSCalibur flow
cytometer with BD CellQuest
TM software. A minimum of
10,000 cells were acquired.
Database analysis and statistical analysis
Results were analysed in Stata v9.2 (Stata Corporation, College
Station, TX) or GraphPad Prism v 4.2 (GraphPad Software, Inc.).
Age, birth weight and maternal haemoglobin levels were normally
distributed and Student’s t-tests were applied and p-values are
given. Total IgG to CS2VSA and phagocytic antibodies both given
as percentage of positive controls (the positive controls being a
pool of sera with known high antibody recognition to CS2) were
not normally distributed, and data were analysed using Mann-
Whitney rank sum tests. Medians and interquartile ranges (IQR)
are given together with the correspondent p-value. All other
variables were categorical. Multiple linear regression models were
used to seek correlations between continuous and categorical
variables and regression coefficients and p-values are given.
Results
Study cohort characteristics according to HIV and
Placental malaria status
One hundred and eighty seven samples were available. Forty
two percent of participants had placental malaria and 65% were
HIV infected (Table 1). Most women (62%) were anaemic, and
mean haemoglobin concentration 6 standard deviation (SD) was
10.662.1 g/dL. Haemoglobin levels were not associated in a
univariate analysis with placental malaria infection or with HIV
status in this study group (Table 1). Infant birth weight did not
vary with placental malaria infection, but was significantly lower
among HIV-positive women (P,0.001, Table 1). Women with
evidence of placental malaria infection were significantly younger
than uninfected women (P=0.002; Table 1). Women were not
more likely to have evidence of placental malaria infection with
either the presence or absence of a concomitant HIV infection
(logistic regression: odds ratio=0.79, p=0.341).
Associations between antibody levels and HIV, placental
malaria status, maternal haemoglobin and infants’ birth
weight
ThecorrelationbetweenthelevelsoftotalIgGtoCS2VSAandthe
phagocytic function in this cohort of secundigravid women was
similar to previous observations (r
2=0.67) The spread of values for
total IgG to CS2VSA was larger than that for phagocytic antibodies.
We compared antibody levels in women with evidence of
placental malaria infection (PM+) and without infection (PM2).
For phagocytic antibodies levels were higher in PM+ women
(median; IQR 11.79; 5.92–79.45) than in PM2 women (6.00;
3.81–8.52; p,0.001). Similarly, Total IgG to CS2VSA was higher
in PM+ women (5.35; 1.77–26.07) than PM2 women (1.75; 0.45–
3.19; p,0.001). Phagocytic antibodies were significantly decreased
in HIV infected women (6.72; 4.22–14.78) compared to HIV
uninfected women (9.21; 5.36–36.98; p=0.011), whereas total IgG
to CS2VSA showed a non-significant difference between HIV-
infected women (2.14; 0.74–6.71) and women who were HIV-
negative (2.97; 1.29–26.20; p=0.079; Figure 1A). Neither
phagocytic antibodies nor total IgG to CS2VSA was correlated
with maternal haemoglobin levels. Infant birth weight was also not
associated with total IgG to CS2VSA (linear regression (LR):
coef=0.007, p=0.223) (Figure 1B) but it was correlated with
phagocytic antibodies (LR: coef=3.34, p=0.034) (Figure 1C).
A multivariate analysis was performed using HIV status,
antibodies and maternal age and weight against infant birth weight
and maternal haemoglobin concentration. Women were divided
into placental-malaria positive and placental-malaria negative.
Total IgG to CS2VSA was not associated with infant birth weight
in either group (data not shown). Phagocytic antibodies were not
associated with infant birth weight in placental-malaria negative
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Age
Maternal Hb
level (g/dL)
1
Infant Bw
(g)
2
n [%] Mean (SD) p-value n [%] Mean (SD) p-value n [%] Mean (SD) p-value
Entire Cohort 187 [100] 22.5 (3.1) 129 [100] 10.6 (2.14) 181 [100] 2852 (518)
HIV negative 65 [35] 22.1(2.3) 30 [23] 10.7 (2.1) 61 [34] 3091 (452)
positive 122 [65] 22.7 (3.4) 0.197 99 [77] 10.6 (2.2) 0.934 120 [66] 2731 (510) ,0.001
Malaria infection negative 89 [48] 23.1 (3.5) 58 [45] 10.9 (2.2) 87 [44] 2852 (561)
positive 79 [42] 21.6 (2.3) 0.002 61 [47] 10.5 (2.0) 0.252 78 [43] 2865 (438) 0.875
Not available 19 [22] 10 [8] 16 [9]
HIV and Malaria:
DOUBLE NEGATIVES
3 27 [14] 22.3 (2.0) 9 [7] 11.1 (2.4) 26 [14] 3112 (501)
DOUBLE POSITIVES
4 47 [25] 21.5 (2.1) 0.119 42 [33] 10.5 (2.0) 0.404 46 [25] 2714 (390) ,0.001
The data represents numbers of patients (percentages of total for each parameter) and means [standard deviations].
1Maternal haemoglobin levels.
2Birth weight of babies at delivery.
3DOUBLE NEGATIVES are women with neither HIV nor malaria.
4DOUBLE POSITIVES are women with both HIV and malaria infection. Variables are normally distributed, so Student’s t-tests were applied.
doi:10.1371/journal.pone.0022491.t001
Figure 1. Associations of antibodies measured with HIV and infant birth weight. A) Values for both phagocytic antibodies (circles) and
total IgG to CS2VSA (squares) were plotted according to the women’s’ HIV status (HIV negative – full symbols; HIV positive – open symbols). Mann-
Whitney rank sum tests were performed on HIV positive vs. negative women. *p=0.010; n.s. ( p=0.078). Univariate linear regression of total IgG to
CS2VSA (B) and phagocytic antibodies (C) and infant birth weight. Both p-values are plotted. Only phagocytic antibodies correlated with infant birth
weight (r
2=0.025, p=0.034).
doi:10.1371/journal.pone.0022491.g001
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22491Figure 2. Effect of HIV on the anti-CS2VSA antibody levels in the ‘No Malaria’ histopathology group. In a univariate analysis of women
that showed no evidence of either peripheral or placental malaria infection, using Mann-Whitney ranksum tests, phagocytic antibodies (A) are shown
to be significantly decreased by HIV infection (z=22.17, p=0.03). On the contrary total IgG to CS2VSA (B) shows a non-significant decrease in the HIV-
positive group (z=21.35, p=0.179. Box, median and interquartile range; whiskers, lowest and highest values. P values are shown.
doi:10.1371/journal.pone.0022491.g002
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associated with birth weight, after adjusting for HIV and maternal
age and weight, in women with placental malaria (LR: coef=3.57,
p=0.025). Neither antibody measurement was associated with
maternal haemoglobin levels in multivariate analyses.
Antibody parameters and placental malaria status
The levels of total IgG to CS2VSA and of phagocytic antibodies
did not vary according to findings on placental histology, (data not
shown), being similar in women with acute, chronic and past
infection (Anova across groups, Total IgG to CS2VSA: p=0.266;
phago: p=0.429) Relatively low numbers diminished the power of
this analysis to assess the effect of HIV on immunity in different
types of placental infection.
In women belonging to the histopathology group ‘No Malaria’
(where no evidence of either peripheral or placental malaria was
detected) sufficient numbers were available for an analysis of the
effect of HIV (n=109). HIV significantly affected the function of
phagocytic antibodies (z=22.17, P=0.03) (Figure 2A), but not
the total IgG to CS2VSA (Z=21.35, P=0.179) (Figure 2B).
Discussion
This study and the study conducted on primigravidae that
preceded it [2] examined the effects of HIV infection on both total
IgG to CS2VSA and phagocytic antibodies to CS2VSA using
histopathology to define malaria in pregnancy. We were
particularly interested in associations between antibody responses
and clinical outcomes in secundigravidae, since important
associations between antibody levels and anaemia or low birth
weight have been reported in this group [10]. Limited sample
numbers restricted our ability to further divide the women
according to the different placental malaria stages, as was done
with the previous study [2].
The mean haemoglobin level of participating women was low
(mean=10.6 g/dL), but the cause of this high prevalence of
anemia is unknown, and likely to be multifactorial in this
population [11]; haemoglobin levels did not differ between HIV-
negative and HIV-positive women, nor between women with and
without placental malaria. HIV infection, but not placental
malaria, significantly influenced infant birth weight.
The correlation between total IgG to CS2VSA and phagocytic
antibodies was similar in strength to the correlation observed in
responses of primigravidae from the same cohort [2]. Both
phagocytic antibodies and total IgG to CS2VSA were higher in
PM+ women than in PM2 women. HIV appeared to have
significantly greater impact on phagocytic antibodies than on total
IgG to CS2VSA (Figure 1). This impact of HIV supports the
hypothesis that, in cohorts of women infected with HIV, IgG sub-
classesthat contributeto phagocytosis aremoreimpaired than those
that do not, as we had suggested in our previous study [2]. Several
studies have shown that different functional antibodies and even
levelsoftotal antibodies do not always correlate well with eachother
when controlling for gravidity or HIV [3,6,12]. Not all the sub-
classes of IgG contribute to the process of phagocytosis. Several
studies have demonstrated that the sub-classes IgG1 and IgG3
(called cytophilic classes due to their high capacity to induce
immune cells to respond) are the most prominent classes among
individuals living in malaria endemic areas that have achieved
partial immunity [13] and are also the sub-classes that elicit
phagocytosis in monocytes and macrophages [3,14,15]. It is
worthwhile to point out that the remaining sub-classes of IgG,
IgG2 and IgG4, have been associated with protection from malaria
symptoms and with susceptibility to it, respectively [16,17,18]. It is
thought that these antibodies, especially IgG4 might compete with
the cytophilic antibodies for epitopes on the surface of the pRBC. In
lightofthis,andbecausenoanalysisofthespecificsub-classesofIgG
and their possible functions (ADCI, anti-adhesion, anti-agglutina-
tion, anti-rosetting, phagocytosis, etc) was performed we cannot
really reach a conclusion to what the function of the remaining IgG
that are not phagocytosis contributors. Also, it should be noted that
our findings may result from characteristics of the techniques
involved to measure those antibodies, which in itself is important to
point out. Not only is phagocytosis a more biologically relevant
measure than total IgG, but it may be a more sensitive one also.
When combined with our previous study, our data show that HIV
affects phagocytic antibodies more than total IgG to CS2VSA and
that it does so to a greater extent in secundigravidae(this study) than
in primigravidae.
When the women were divided according to presence or
absence of PM, levels of total IgG to CS2VSA were not associated
with birth weight or haemoglobin levels in either group. On the
other hand, phagocytic antibodies to CS2VSA showed an
association with birth weight, and within PM+ women this
association remained after controlling for HIV, maternal age and
maternal weight. Infant birth weight increased 3.57 g per unit of
antibody measured (coef=3.57, p=0.025). Our observations have
similarities to those of Duffy et al, who measured anti-adhesion
antibodies and identified secundigravidae as a particular impor-
tant group in the search for associations between antibodies and
outcomes [10]. Being in a position of transition between
susceptible primigravidae and immune multigravidae, secundi-
gravidae present a very interesting focus of research. Although the
numbers of women were not enough to completely dissect the role
of these antibodies according to the different PM groups, the fact
that in the ‘No malaria’ group HIV positive women had lower
levels of phagocytic antibodies than did HIV negative women
(with no significant differences for total IgG to CS2VSA) seems to
confirm the results obtained in the PG group for women with past
infection obtained in our previous study [2].
This study, although recognisably limited by the number of
samples available, shed light into important areas of interest in
the field of acquired immunity to malaria in pregnancy. First it
revealed that phagocytic antibodies may be a more accurate
measure of protective immunity than total IgG to CS2VSA.
Second, it demonstrated that HIV has a bigger impact on
phagocytic antibodies than on the total level of IgG to CS2VSA.
Finally, it showed us that secundigravidae, who are acquiring
protective immunity, can be an important group for the
detection of associations between antibodies and clinical
outcomes. These points are of particular interest when designing
studies looking at the development of immunity to malaria in
pregnancy in settings of HIV co-infection, where most vaccine
trials are taking place.
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